Baseline characteristics

Cisplatin With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer · Source last updated 2017-05-03

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms

1. counts

   1. group Id

      BG000

      value

      6

   2. group Id

      BG001

      value

      0

   3. group Id

      BG002

      value

      6

   units

   Participants

groups

1. description

   Patients receive WEE1 inhibitor MK-1775 PO BID for 5 doses beginning on day 1 and cisplatin IV over 1 hour on day 1. Cisplatin: Given IV Laboratory Biomarker Analysis: Correlative studies Pharmacological Study: Correlative studies WEE1 Inhibitor AZD1775: Given PO

   id

   BG000

   title

   Arm I (WEE1 Inhibitor MK-1775, Cisplatin)

2. description

   Patients receive placebo PO BID for 5 doses beginning on day 1 and cisplatin IV over 2 hour on day 1. Cisplatin: Given IV Laboratory Biomarker Analysis: Correlative studies Pharmacological Study: Correlative studies Placebo: Given PO

   id

   BG001

   title

   Arm II (Placebo, Cisplatin)

3. description

   Total of all reporting groups

   id

   BG002

   title

   Total

measures

1. classes

   1. categories

      1. measurements

         1. group Id

            BG000

            value

            0

         2. group Id

            BG002

            value

            0

         title

         <=18 years

      2. measurements

         1. group Id

            BG000

            value

            3

         2. group Id

            BG002

            value

            3

         title

         Between 18 and 65 years

      3. measurements

         1. group Id

            BG000

            value

            3

         2. group Id

            BG002

            value

            3

         title

         >=65 years

   param Type

   COUNT_OF_PARTICIPANTS

   title

   Age, Categorical

   unit Of Measure

   Participants

2. classes

   1. categories

      1. measurements

         1. group Id

            BG000

            lower Limit

            56

            upper Limit

            84

            value

            66

         2. group Id

            BG002

            lower Limit

            56

            upper Limit

            84

            value

            66

   dispersion Type

   FULL_RANGE

   param Type

   MEDIAN

   title

   Age, Continuous

   unit Of Measure

   years

3. classes

   1. categories

      1. measurements

         1. group Id

            BG000

            value

            1

         2. group Id

            BG002

            value

            1

         title

         Female

      2. measurements

         1. group Id

            BG000

            value

            5

         2. group Id

            BG002

            value

            5

         title

         Male

   param Type

   COUNT_OF_PARTICIPANTS

   title

   Sex: Female, Male

   unit Of Measure

   Participants

4. classes

   1. categories

      1. measurements

         1. group Id

            BG000

            value

            6

         2. group Id

            BG002

            value

            6

      title

      Canada

   param Type

   NUMBER

   title

   Region of Enrollment

   unit Of Measure

   participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice